ASCO 2018: Blood test shows potential as a detection tool for early-stage lung cancer

10:07 EDT 2 Jun 2018 | ecancermedicalscience

An initial report from the large, ongoing Circulating Cell-Free Genome Atlas (CCGA) study provides preliminary evidence that a blood test may be able to detect early-stage lung cancer. This is one of the first studies to explore blood tests analysing...

More From BioPortfolio on "ASCO 2018: Blood test shows potential as a detection tool for early-stage lung cancer"